These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 17028986

  • 1. Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors.
    Cauley JA, Song J, Dowsett SA, Mershon JL, Cummings SR.
    Breast Cancer Res Treat; 2007 Apr; 102(2):181-8. PubMed ID: 17028986
    [Abstract] [Full Text] [Related]

  • 2. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL, Song J, Dowsett SA, Mershon JL, Delmas PD, Secrest RJ, Cauley JA.
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [Abstract] [Full Text] [Related]

  • 3. Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk.
    Lippman ME, Cummings SR, Disch DP, Mershon JL, Dowsett SA, Cauley JA, Martino S.
    Clin Cancer Res; 2006 Sep 01; 12(17):5242-7. PubMed ID: 16951244
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapy.
    Johnell O, Cauley JA, Kulkarni PM, Wong M, Stock JL.
    J Fam Pract; 2004 Oct 01; 53(10):789-96. PubMed ID: 15469774
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone mineral density and risk of postmenopausal breast cancer.
    Grenier D, Cooke AL, Lix L, Metge C, Lu H, Leslie WD.
    Breast Cancer Res Treat; 2011 Apr 01; 126(3):679-86. PubMed ID: 20838879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention and treatment of osteoporosis in women with breast cancer.
    Mincey BA, Moraghan TJ, Perez EA.
    Mayo Clin Proc; 2000 Aug 01; 75(8):821-9. PubMed ID: 10943237
    [Abstract] [Full Text] [Related]

  • 11. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB, Fontana A, Guastalla JP, Munoz F, Brun J, Delmas PD.
    Bone; 2007 Sep 01; 41(3):346-52. PubMed ID: 17618847
    [Abstract] [Full Text] [Related]

  • 12. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
    Lee WL, Chao HT, Cheng MH, Wang PH.
    Maturitas; 2008 Jun 20; 60(2):92-107. PubMed ID: 18534794
    [Abstract] [Full Text] [Related]

  • 13. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.
    Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM, Cauleys JA.
    Cancer Epidemiol Biomarkers Prev; 2005 May 20; 14(5):1047-51. PubMed ID: 15894651
    [Abstract] [Full Text] [Related]

  • 14. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women.
    Grady D, Vittinghoff E, Lin F, Hanes V, Ensrud K, Habel LA, Wallace R, Macer J, Cummings SR, Shepherd J.
    Menopause; 2007 May 20; 14(3 Pt 1):391-6. PubMed ID: 17224859
    [Abstract] [Full Text] [Related]

  • 15. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
    Reeves KW, Faulkner K, Modugno F, Hillier TA, Bauer DC, Ensrud KE, Cauley JA, Study of Osteoporotic Fractures Research Group.
    Cancer Epidemiol Biomarkers Prev; 2007 Jul 20; 16(7):1468-73. PubMed ID: 17627012
    [Abstract] [Full Text] [Related]

  • 16. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L, Iversen OE, Rudenstam CM, Hammar M, Kumpulainen E, Jaskiewicz J, Jassem J, Dobaczewska D, Fjosne HE, Peralta O, Arriagada R, Holmqvist M, Maenpaa J, HABITS Study Group.
    J Natl Cancer Inst; 2008 Apr 02; 100(7):475-82. PubMed ID: 18364505
    [Abstract] [Full Text] [Related]

  • 17. Measures of adiposity and risk of breast cancer in older postmenopausal women.
    Krebs EE, Taylor BC, Cauley JA, Stone KL, Bowman PJ, Ensrud KE.
    J Am Geriatr Soc; 2006 Jan 02; 54(1):63-9. PubMed ID: 16420199
    [Abstract] [Full Text] [Related]

  • 18. Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.
    Chen Z, Maricic M, Pettinger M, Ritenbaugh C, Lopez AM, Barad DH, Gass M, Leboff MS, Bassford TL.
    Cancer; 2005 Oct 01; 104(7):1520-30. PubMed ID: 16110508
    [Abstract] [Full Text] [Related]

  • 19. Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure.
    Shapiro CL, Phillips G, Van Poznak CH, Jackson R, Leboff MS, Woodard S, Lemeshow S.
    Breast Cancer Res Treat; 2005 Mar 01; 90(1):41-6. PubMed ID: 15770525
    [Abstract] [Full Text] [Related]

  • 20. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
    Popp AW, Bodmer C, Senn C, Fuchs G, Kraenzlin ME, Wyss H, Birkhaeuser MH, Lippuner K.
    Maturitas; 2006 Jan 20; 53(2):191-200. PubMed ID: 16368472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.